Zheng-ting Deng , Shu-fang Liang , Guo-kai Huang , Yu-qian Wang , Xiao-yu Tu , Ya-ni Zhang , Shu Li , Tao Liu , Bin-bin Cheng
{"title":"自噬在三氧化二砷诱导的肝癌细胞死亡中发挥促进凋亡的作用","authors":"Zheng-ting Deng , Shu-fang Liang , Guo-kai Huang , Yu-qian Wang , Xiao-yu Tu , Ya-ni Zhang , Shu Li , Tao Liu , Bin-bin Cheng","doi":"10.1016/j.joim.2024.03.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The effects of arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) on hepatocellular carcinoma have been documented widely. Autophagy plays dual roles in the survival and death of cancer cells. Therefore, we investigated the exact role of autophagy in As<sub>2</sub>O<sub>3</sub>-induced apoptosis in liver cancer cells.</p></div><div><h3>Methods</h3><p>The viability of hepatoma cells was determined using the MTT assay with or without fetal bovine serum. The rate of apoptosis in liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was evaluated using flow cytometry, Hoechst 33258 staining, and TUNEL assays. The rate of autophagy among liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was detected using immunofluorescence, Western blot assay and transmission electron microscopy.</p></div><div><h3>Results</h3><p>Upon treatment with As<sub>2</sub>O<sub>3</sub>, the viability of HepG2 and SMMC-7721 cells was decreased in a time- and dose-dependent manner. The apoptosis rates of both liver cancer cell lines increased with the concentration of As<sub>2</sub>O<sub>3</sub>, as shown by flow cytometry. Apoptosis in liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was also shown by the activation of the caspase cascade and the regulation of Bcl-2/Bax expression. Furthermore, As<sub>2</sub>O<sub>3</sub> treatment induced autophagy in liver cancer cells; this finding was supported by Western blot, immunofluorescence of LC3-II and beclin 1, and transmission electron microscopy. In liver cancer cells, As<sub>2</sub>O<sub>3</sub> inhibited the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin <strong>(</strong>PI3K/AKT/mTOR) signal pathway that plays a vital role in both apoptosis and autophagy. The PI3K activator SC-79 partially reversed As<sub>2</sub>O<sub>3</sub><strong>-</strong>induced autophagy and apoptosis. Furthermore, inhibiting autophagy with 3-methyladenine partially reversed the negative effects of As<sub>2</sub>O<sub>3</sub> on cell viability. Serum starvation increased autophagy and amplified the effect of As<sub>2</sub>O<sub>3</sub> on cell death.</p></div><div><h3>Conclusion</h3><p>As<sub>2</sub>O<sub>3</sub> induces apoptosis and autophagy in liver cancer cells. Autophagy induced by As<sub>2</sub>O<sub>3</sub> may have a proapoptotic effect that helps to reduce the viability of liver cancer cells. This study provides novel insights into the effects of As<sub>2</sub>O<sub>3</sub> against liver cancer.</p><p>Please cite this article as: Deng ZT, Liang SF, Huang GK, Wang YQ, Tu XY, Zhang YN, Li S, Liu T, Cheng BB. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer. <em>J Integr Med</em>. 2024; 22(3): 295–302.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":"22 3","pages":"Pages 295-302"},"PeriodicalIF":4.2000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer\",\"authors\":\"Zheng-ting Deng , Shu-fang Liang , Guo-kai Huang , Yu-qian Wang , Xiao-yu Tu , Ya-ni Zhang , Shu Li , Tao Liu , Bin-bin Cheng\",\"doi\":\"10.1016/j.joim.2024.03.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>The effects of arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) on hepatocellular carcinoma have been documented widely. Autophagy plays dual roles in the survival and death of cancer cells. Therefore, we investigated the exact role of autophagy in As<sub>2</sub>O<sub>3</sub>-induced apoptosis in liver cancer cells.</p></div><div><h3>Methods</h3><p>The viability of hepatoma cells was determined using the MTT assay with or without fetal bovine serum. The rate of apoptosis in liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was evaluated using flow cytometry, Hoechst 33258 staining, and TUNEL assays. The rate of autophagy among liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was detected using immunofluorescence, Western blot assay and transmission electron microscopy.</p></div><div><h3>Results</h3><p>Upon treatment with As<sub>2</sub>O<sub>3</sub>, the viability of HepG2 and SMMC-7721 cells was decreased in a time- and dose-dependent manner. The apoptosis rates of both liver cancer cell lines increased with the concentration of As<sub>2</sub>O<sub>3</sub>, as shown by flow cytometry. Apoptosis in liver cancer cells treated with As<sub>2</sub>O<sub>3</sub> was also shown by the activation of the caspase cascade and the regulation of Bcl-2/Bax expression. Furthermore, As<sub>2</sub>O<sub>3</sub> treatment induced autophagy in liver cancer cells; this finding was supported by Western blot, immunofluorescence of LC3-II and beclin 1, and transmission electron microscopy. In liver cancer cells, As<sub>2</sub>O<sub>3</sub> inhibited the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin <strong>(</strong>PI3K/AKT/mTOR) signal pathway that plays a vital role in both apoptosis and autophagy. The PI3K activator SC-79 partially reversed As<sub>2</sub>O<sub>3</sub><strong>-</strong>induced autophagy and apoptosis. Furthermore, inhibiting autophagy with 3-methyladenine partially reversed the negative effects of As<sub>2</sub>O<sub>3</sub> on cell viability. Serum starvation increased autophagy and amplified the effect of As<sub>2</sub>O<sub>3</sub> on cell death.</p></div><div><h3>Conclusion</h3><p>As<sub>2</sub>O<sub>3</sub> induces apoptosis and autophagy in liver cancer cells. Autophagy induced by As<sub>2</sub>O<sub>3</sub> may have a proapoptotic effect that helps to reduce the viability of liver cancer cells. This study provides novel insights into the effects of As<sub>2</sub>O<sub>3</sub> against liver cancer.</p><p>Please cite this article as: Deng ZT, Liang SF, Huang GK, Wang YQ, Tu XY, Zhang YN, Li S, Liu T, Cheng BB. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer. <em>J Integr Med</em>. 2024; 22(3): 295–302.</p></div>\",\"PeriodicalId\":48599,\"journal\":{\"name\":\"Journal of Integrative Medicine-Jim\",\"volume\":\"22 3\",\"pages\":\"Pages 295-302\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Integrative Medicine-Jim\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S209549642400044X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Medicine-Jim","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S209549642400044X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer
Objective
The effects of arsenic trioxide (As2O3) on hepatocellular carcinoma have been documented widely. Autophagy plays dual roles in the survival and death of cancer cells. Therefore, we investigated the exact role of autophagy in As2O3-induced apoptosis in liver cancer cells.
Methods
The viability of hepatoma cells was determined using the MTT assay with or without fetal bovine serum. The rate of apoptosis in liver cancer cells treated with As2O3 was evaluated using flow cytometry, Hoechst 33258 staining, and TUNEL assays. The rate of autophagy among liver cancer cells treated with As2O3 was detected using immunofluorescence, Western blot assay and transmission electron microscopy.
Results
Upon treatment with As2O3, the viability of HepG2 and SMMC-7721 cells was decreased in a time- and dose-dependent manner. The apoptosis rates of both liver cancer cell lines increased with the concentration of As2O3, as shown by flow cytometry. Apoptosis in liver cancer cells treated with As2O3 was also shown by the activation of the caspase cascade and the regulation of Bcl-2/Bax expression. Furthermore, As2O3 treatment induced autophagy in liver cancer cells; this finding was supported by Western blot, immunofluorescence of LC3-II and beclin 1, and transmission electron microscopy. In liver cancer cells, As2O3 inhibited the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signal pathway that plays a vital role in both apoptosis and autophagy. The PI3K activator SC-79 partially reversed As2O3-induced autophagy and apoptosis. Furthermore, inhibiting autophagy with 3-methyladenine partially reversed the negative effects of As2O3 on cell viability. Serum starvation increased autophagy and amplified the effect of As2O3 on cell death.
Conclusion
As2O3 induces apoptosis and autophagy in liver cancer cells. Autophagy induced by As2O3 may have a proapoptotic effect that helps to reduce the viability of liver cancer cells. This study provides novel insights into the effects of As2O3 against liver cancer.
Please cite this article as: Deng ZT, Liang SF, Huang GK, Wang YQ, Tu XY, Zhang YN, Li S, Liu T, Cheng BB. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer. J Integr Med. 2024; 22(3): 295–302.
期刊介绍:
The predecessor of JIM is the Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao). With this new, English-language publication, we are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine.
JIM is indexed/abstracted in: MEDLINE/PubMed, ScienceDirect, Emerging Sources Citation Index (ESCI), Scopus, Embase, Chemical Abstracts (CA), CAB Abstracts, EBSCO, WPRIM, JST China, Chinese Science Citation Database (CSCD), and China National Knowledge Infrastructure (CNKI).
JIM Editorial Office uses ThomsonReuters ScholarOne Manuscripts as submitting and review system (submission link: http://mc03.manuscriptcentral.com/jcim-en).
JIM is published bimonthly. Manuscripts submitted to JIM should be written in English. Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, clinical trial protocols, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor.
Our purpose is to publish a prestigious international journal for studies in integrative medicine. To achieve this aim, we seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, taichi, qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered. These ensure that articles published in JIM have the maximum exposure to the international scholarly community.
JIM can help its authors let their papers reach the widest possible range of readers, and let all those who share an interest in their research field be concerned with their study.